-
Telemedicine platform will help eye care professionals build their skills
Wednesday, September 2, 2020Santen and Orbis International has announced a partnership to develop a suite of digital training tools that will continue to help eyecare professionals around the world build their skills.
-
Hydrophobic acrylic IOL
Wednesday, September 2, 2020VSY Biotechnology has announced the launch of Enova, a 100% glistening-free IOL
-
Precision OCT analyser
Wednesday, September 2, 2020Haag-Streit Diagnostics has announced the introduction of Eyestar 900, the precision OCT analyser.
-
FDA Clearance of CATALYS cOS 6.0 Software
Wednesday, September 2, 2020Johnson & Johnson Vision has announced the Food and Drug Administration (FDA) 510(k) clearance of a new software for the CATALYS Precision Laser System.
-
FDA acceptance of PMA application
Wednesday, September 2, 2020Santen has announced that the United States Food and Drug Administration (FDA) has accepted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
-
Following in great footsteps
Wednesday, September 2, 2020Andreas Bosshard(left), co-owner and former managing director of Oertli Instrumente AG, has handed over the chairmanship of the board to Andreas Schmidheini. Mr Bosshard joined Oertli Instrumente AG and took over as managing director in 1989. Heinz A. Oertli, the founder of the company, had hired Mr Bosshard, who had experience as a development, sales […]
-
New platform of preloaded intraocular lenses
Thursday, July 30, 2020BAUSCH + LOMB has announced the launch of a new platform of preloaded intraocular lenses LUXSMART™ AND LUXGOOD™, which feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. LuxSmart™ and LuxGood™ comprise a hydrophobic material and represent the launch of a new platform for Bausch + Lomb, forming part of a complete range of […]
-
Microbiome research
Thursday, July 30, 2020ZEISS have established a partnership with microbiome analytics firm Perseus Biomics. The partnership aims to develop an optical technology for microbiome research, specifically the quantitative analysis of the microbiome. “The microbiome is a field of strong research interest with the potential to fundamentally change our understanding of living systems. Abundance analysis of the microbiome is […]
-
Acquisition completed
Thursday, July 30, 2020AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court. “We are pleased to reach this important milestone for the Company, its employees, shareholders and the patients we serve,” […]
-
New regional vice-president
Thursday, July 30, 2020Johnson & Johnson Vision has appointed Erin McEachren as Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. “Erin is an exceptional leader with a strong track record of success and a depth and breadth of experience. Her addition to the global Surgical Vision Leadership Team strengthens our position at the highest level of […]
